Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rajesh Kumar Suman"'
Publikováno v:
MGM Journal of Medical Sciences, Vol 9, Iss 4, Pp 509-516 (2022)
Background: Tridax procumbens Linn. is a spreading herb found throughout India. Tridax procumbens is known for several potential therapeutic effects like antiviral, antioxidant, anti-infective, wound healing, insecticidal and anti-inflammatory, hepat
Externí odkaz:
https://doaj.org/article/a5f8088f716c412a9b14c612d06ad19d
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 3, Pp FF13-FF18 (2016)
Introduction: Berberine, an isoquinoline alkaloid isolated from the Berberis aristata, has been shown to display a wide array of pharmacological activities (hypoglycaemic and hypolipidemic). Aim: The present study was designed to investigate wheth
Externí odkaz:
https://doaj.org/article/115c037ad9794d4fad8bde0b4c2a785f
Autor:
Rajesh Kumar Suman, Ipseeta Ray Mohanty, Manjusha K. Borde, Ujwala Maheshwari, Y. A. Deshmukh
Publikováno v:
Advances in Pharmacological Sciences, Vol 2016 (2016)
Background. The incidence of metabolic syndrome co-existing with diabetes mellitus is on the rise globally. Objective. The present study was designed to develop a unique animal model that will mimic the pathological features seen in individuals with
Externí odkaz:
https://doaj.org/article/de5f5acaab64443281b05822b48f1084
Publikováno v:
International Journal of Pharmacological Research, Vol 11, Iss 3 (2021)
Objectives: The marketed synthetic Dipeptidyl peptidase-IV (DPP-IV) inhibitors are expensive antidiabetic drugs and have been reported to cause unacceptable adverse effects. In this scenario research to develop novel DPP-IV inhibitors from alternativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2ac984dd23aebeb746fb4c413769ec94
https://www.ssjournals.com/index.php/ijpr/article/view/5584
https://www.ssjournals.com/index.php/ijpr/article/view/5584
Autor:
Ujwala Maheshwari, Manjusha K. Borde, Ipseeta Ray Mohanty, Y. A. Deshmukh, Rajesh Kumar Suman
Publikováno v:
Journal of Diabetes, Metabolic Disorders & Control. 5:48-56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d2c55ae8e8c36b3c7da4430bd5b21da
https://doi.org/10.15406/jdmdc.2018.05.00137
https://doi.org/10.15406/jdmdc.2018.05.00137
Publikováno v:
International Journal of Clinical Endocrinology and Metabolism. 3:018-022
Background: Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefi ts in diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::132bd0019745d511cf3553b0d407ccfa
https://doi.org/10.17352/ijcem.000024
https://doi.org/10.17352/ijcem.000024
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 10:420
Background: Prescribing patterns provides prescribing behaviors of prescriber. Hypertension is most common cardiac complication among middle and old age population. Thus, study about prescribing trends helps to select appropriate drug for treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fd326024a044d115264ea8abf7eb025
https://doi.org/10.18203/2319-2003.ijbcp20211026
https://doi.org/10.18203/2319-2003.ijbcp20211026
Publikováno v:
Metabolism. 116:154504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6db84e337a0d27137ddc79d290ab666
https://doi.org/10.1016/j.metabol.2020.154504
https://doi.org/10.1016/j.metabol.2020.154504
Autor:
Rajesh Kumar Suman, Ipseeta Ray Mohanty, Ujwala Maheshwari, Y. A. Deshmukh, Manjusha K. Borde
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :1053-1061
Background: Vildagliptin has multiple beneficial effects reported in isolated studies like anti-diabetic, cardio protective, anti-inflammatory and antioxidant. However, there is no experimental evidence presently available with regard to the possible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::081bdb26eb53ac354ea630c595b9fd5b
https://doi.org/10.18203/2319-2003.ijbcp20161568
https://doi.org/10.18203/2319-2003.ijbcp20161568
Autor:
Ipseeta Ray Mohanty, Ujwala Maheshwari, Manjusha K. Borde, Rajesh Kumar Suman, Y. A. Deshmukh
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :341-349
Background: Several epidemiological studies have found that in type II diabetic patients, Metformin improves vascular function and reduces cardiovascular events and mortality by mechanisms that are not entirely attributed to its anti- hyperglycemic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9675db4cb104c85f1bbe9921c4b13de
https://doi.org/10.18203/2319-2003.ijbcp20160742
https://doi.org/10.18203/2319-2003.ijbcp20160742